metricas
Gastroenterología y Hepatología (English Edition) Metastasis from primary lung cancer of unusual location
Journal Information
Vol. 47. Issue 2.
Pages 186-187 (February 2024)
Image of the month
Full text access

Metastasis from primary lung cancer of unusual location

Metástasis de origen pulmonar de localización inusual
Visits
348
Carmen Pradera Cibreiroa,
Corresponding author
carmen.pradera@hotmail.com

Corresponding author.
, Marta Ramos Alonsoa, Rafael Lago Cascudob, Martín Fernández Lópeza, Diana Alejandra Rivera Castilloa, María Violeta Mauriz Barreiroa
a Servicio de Aparato Digestivo, Complejo Hospitalario Universitario de Ferrol, Ferrol, A Coruña, Spain
b Servicio de Anatomía Patológica, Complejo Hospitalario Universitario de Ferrol, Ferrol, A Coruña, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
fig0005
fig0010
fig0015
Show moreShow less
Full Text

This was a 64-year-old man undergoing chemotherapy for TNM stage T4N2M0 squamous cell carcinoma of the lung.

A follow-up CT scan 10 months after diagnosis showed mural thickening of the ascending colon (Fig. 1). A colonoscopy was performed and a superficial ulcer of non-specific appearance was observed in the right colon (Fig. 2). Histopathology was consistent with colonic metastasis of lung squamous cell carcinoma (Fig. 3).

Figure 1.

CT scan: asymmetric mural thickening of the ascending colon (arrow) with fat reticulation and adjacent vascular engorgement.

Figure 2.

Endoscopic findings: ulcerated lesion in ascending colon.

Figure 3.

Pathology: (A) haematoxylin-eosin ×2: colon biopsy with marked inflammation (arrow); and (B) haematoxylin-eosin ×10: colon biopsy with neoplastic cellular nidus. (C) Neoplastic cellularity positive for anti-P40 antibody in colon (×20); and (D) endobronchial primary lesion (×20) confirming squamous origin.

Currently, 6 months after the endoscopy, the patient still has no gastrointestinal symptoms and is being treated with the previous chemotherapy regimen.

Gastrointestinal (GI) metastases from primary lung cancer are rare, varying in incidence between 0.3% and 1.7%. The most common GI sites are the oesophagus (6.3%), small intestine (2.6%), stomach (1.2%) and colon (0.7%).1

The histological subtype of primary lung neoplasm most commonly associated with GI metastases is much debated,2 with a recent series finding large cell carcinoma to be the most prevalent.1

Most of these patients are asymptomatic.3,4 Treatment is usually chemotherapy, although in complicated cases (perforation, obstruction, haemorrhage, etc.) surgery may be considered. No therapy has been shown to have an impact on survival.1

References
[1]
A. Balla, J.D. Subiela, J. Bollo, C. Martinez, C. Rodriguez Luppi, P. Hernandez, et al.
Gastrointestinal metastasis from primary lung cancer. Case series and systematic literature review.
Cir Esp (Engl Ed), 96 (2018), pp. 184-197
[2]
B.K. Goh, A.W. Yeo, H.N. Koong, L.L. Ooi, W.K. Wong.
Laparotomy for acute complications of gastrointestinal metastases from lung cancer: is it a worthwhile or futile effort?.
Surg Today, 37 (2007), pp. 370-374
[3]
J.Z. Di, J.Y. Peng, Z.G. Wang.
Prevalence, clinicopathological characteristics, treatment, and prognosis of intestinal metastasis of primary lung cancer: a comprehensive review.
Surg Oncol, 23 (2014), pp. 72-80
[4]
M.S. Kim, E.H. Kook, S.H. Ahn, S.Y. Jeon, J.H. Yoon, M.S. Han, et al.
Gastrointestinal metastasis of lung cancer with special emphasis on a long-term survivor after operation.
J Cancer Res Clin Oncol, 135 (2009), pp. 297-301
Copyright © 2023. Elsevier España, S.L.U.. All rights reserved